Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer: results from a large observational cohort study (BRiTE) (Q82294729)
Jump to navigation
Jump to search
scientific article published on 14 October 2008
Language | Label | Description | Also known as |
---|---|---|---|
English | Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer: results from a large observational cohort study (BRiTE) |
scientific article published on 14 October 2008 |
Statements
Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer: results from a large observational cohort study (BRiTE) (English)
Axel Grothey
Mary M Sugrue
David M Purdie
Wei Dong
Eric Hedrick